Safety/Immunogenicity Hantaan Virus DNA Vaccine and Puumala Virus DNA Vaccine, For Prevention of HFRS

Clinical trial NCT04333459 · COMPLETED

Trial details

NCT number: NCT04333459
Sponsor: U.S. Army Medical Research and Development Command
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hantaan Virus Nephropathy Puumala Virus Nephropathy

Start date: 2021-08-23
Primary completion: 2024-10-15
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.